ID
13666
Description
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00262782
Link
https://clinicaltrials.gov/show/NCT00262782
Keywords
Versions (1)
- 2/24/16 2/24/16 -
Uploaded on
February 24, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Leukemia NCT00262782
Eligibility Leukemia NCT00262782
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia NCT00262782
- StudyEvent: Eligibility
C0332448 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2])